Fig. 4From: Role of sclerostin in the pathogenesis of chronic kidney disease-mineral bone disorderDistribution of serum sclerostin levels in 30 controls (a) and 102 hemodialysis patients (b). a Median level 1.15 ng/ml (IQR 0.93–1.46 ng/ml). b Median level 15.2 ng/ml (IQR 11.3–22.3 ng/ml) [44]Back to article page